Literature DB >> 6434835

Paired comparisons between early treated PKU children and their matched sibling controls on intelligence and school achievement test results at eight years of age.

R Koch, C Azen, E G Friedman, M L Williamson.   

Abstract

Early-treated PKU children were compared to their matched non-PKU sibling controls on Wechsler Intelligence Scale for Children (WISC) and Wide Range Achievement Test (WRAT) results at age 8. Fifty-five PKU children had mean WISC Full Scale IQ score of 100, in comparison to a mean of 107 for their matched sibling controls (p = 0.001). Treatment parameters significantly correlated with sibling-PKU IQ score differences included maximum diagnostic phe level (r = 0.244, p = 0.036) and phe levels at age 6 (r = 0.329, p = 0.007) and at age 8 (r = 0.489, p less than 0.0005). Fifty PKU subjects scored significantly lower than their matched sibling controls on standard scores of the WRAT Reading (102 vs. 107, p = 0.016) and Arithmetic (96 vs, 101, p = 0.006) subtests, and lower, but not significantly so, in Spelling (100 vs. 103, p = 0.145). When the sample was grouped according to diet status at age 8, on-diet PKUs scored at or above the level achieved by their siblings on all three scales of the WISC and all three WRAT subtests, whereas the off-diet group scored from 7 to 13 points below their siblings on all measures. These results suggest that PKU children should restrict phe intake at least through their school years.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6434835     DOI: 10.1007/bf01805813

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  4 in total

1.  Intellectual performance of 36 phenylketonuria patients and their nonaffected siblings.

Authors:  J C Dobson; E Kushida; M Williamson; E G Friedman
Journal:  Pediatrics       Date:  1976-07       Impact factor: 7.124

2.  Preliminary report on the effects of diet discontinuation in PKU.

Authors:  R Koch; C G Azen; E G Friedman; M L Williamson
Journal:  J Pediatr       Date:  1982-06       Impact factor: 4.406

3.  Correlates of intelligence test results in treated phenylketonuric children.

Authors:  M L Williamson; R Koch; C Azen; C Chang
Journal:  Pediatrics       Date:  1981-08       Impact factor: 7.124

4.  Collaborative study of children treated for phenylketonuria: study design.

Authors:  M Williamson; J C Dobson; R Koch
Journal:  Pediatrics       Date:  1977-12       Impact factor: 7.124

  4 in total
  19 in total

Review 1.  Food products made with glycomacropeptide, a low-phenylalanine whey protein, provide a new alternative to amino Acid-based medical foods for nutrition management of phenylketonuria.

Authors:  Sandra C van Calcar; Denise M Ney
Journal:  J Acad Nutr Diet       Date:  2012-08       Impact factor: 4.910

2.  Linking genotypes database with locus-specific database and genotype-phenotype correlation in phenylketonuria.

Authors:  Sarah Wettstein; Jarl Underhaug; Belen Perez; Brian D Marsden; Wyatt W Yue; Aurora Martinez; Nenad Blau
Journal:  Eur J Hum Genet       Date:  2014-06-18       Impact factor: 4.246

3.  Randomised controlled trial of tyrosine supplementation on neuropsychological performance in phenylketonuria.

Authors:  M L Smith; W B Hanley; J T Clarke; P Klim; W Schoonheyt; V Austin; D C Lehotay
Journal:  Arch Dis Child       Date:  1998-02       Impact factor: 3.791

Review 4.  Metabolic syndromes with dermatologic manifestations.

Authors:  M Irons; H L Levy
Journal:  Clin Rev Allergy       Date:  1986-02

5.  Pyruvate and creatine prevent oxidative stress and behavioral alterations caused by phenylalanine administration into hippocampus of rats.

Authors:  Simone Luisa Berti; Guilherme Marmontel Nasi; Cristina Garcia; Fernanda Luz de Castro; Michely Lopes Nunes; Denise Bertin Rojas; Tarsila Barros Moraes; Carlos Severo Dutra-Filho; Clóvis Milton Duval Wannmacher
Journal:  Metab Brain Dis       Date:  2011-11-19       Impact factor: 3.584

6.  Results of psychological testing of patients aged 3-6 years.

Authors:  U Michel; E Schmidt; U Batzler
Journal:  Eur J Pediatr       Date:  1990       Impact factor: 3.183

7.  Intelligence and quality of dietary treatment in phenylketonuria.

Authors:  I Smith; M G Beasley; A E Ades
Journal:  Arch Dis Child       Date:  1990-05       Impact factor: 3.791

Review 8.  Phenylketonuria due to phenylalanine hydroxylase deficiency: an unfolding story. Medical Research Council Working Party on Phenylketonuria.

Authors: 
Journal:  BMJ       Date:  1993-01-09

Review 9.  Dietary interventions for phenylketonuria.

Authors:  Vanessa J Poustie; Joanne Wildgoose
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

10.  Bony changes of PKU neonates unrelated to phenylalanine levels.

Authors:  R O Fisch; S B Feinberg; S Weisberg; D Day
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.